Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to gvonge,Shelford,GrahamPlatt,gpadsa,Steffers0, for Donating to support the site

AstraZeneca PLC (AZN)

Share latest information on individual companies and hot news discussions. LSE Main Market companies only
Forum rules
No penny shares or promotional posts
Post Reply Previous topicNext topic
idpickering
The full Lemon
Posts: 11470
Joined: November 4th, 2016, 5:04 pm
Has thanked: 2483 times
Been thanked: 5835 times

Re: AstraZeneca PLC (AZN)

#663230

Postby idpickering » May 7th, 2024, 7:24 am

AstraZeneca completes Cellectis equity investment

AstraZeneca today announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company.


https://www.investegate.co.uk/announcem ... nt/8177375

Ian.
Top
idpickering
The full Lemon
Posts: 11470
Joined: November 4th, 2016, 5:04 pm
Has thanked: 2483 times
Been thanked: 5835 times

Re: AstraZeneca PLC (AZN)

#664504

Postby idpickering » May 16th, 2024, 7:26 am

SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population

Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca's sipavibart (formerly AZD3152), an investigational long-acting antibody (LAAB), demonstrated a statistically significant reduction in the incidence of symptomatic COVID‑19 compared to control (tixagevimab/cilgavimab or placebo) in an immunocompromised patient population.


https://www.investegate.co.uk/announcem ... nt/8200091

Ian.
Top
Post Reply Previous topicNext topic

Return to “Company Share news (LSE Main Market)”

Who is online

Users browsing this forum: No registered users and 5 guests